IA
ATEX icon

IndexIQ Advisors’s Anterix ATEX Stock Holding History

IndexIQ Advisors’s Portfolio ATEX Stock Details ATEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,586
Closed -$172K – 1139
2020
Q4 		$172K Buy
4,586
+473
+12% +$15.6K 0.01% 949
2020
Q3 		$135K Buy
4,113
+224
+6% +$9.48K 0.01% 880
2020
Q2 		$176K Sell
3,889
-400
-9% -$20.4K 0.01% 701
2020
Q1 		$196K Buy
+4,289
New +$194K 0.01% 329

Other funds holding ATEX

OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCC
Bain Capital Credit Boston, Massachusetts $368M AUM 9.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

IndexIQ Advisors's ATEX Position: Q1 2021 in Review

IndexIQ Advisors sold out of Anterix (ATEX) in Q1 2021, closing a stake of 4,586 shares — an estimated $172K sold.

IndexIQ Advisors first reported a position in ATEX in Q1 2020 and held it in 4 quarters. The position peaked at $196K in Q1 2020. 97 funds tracked by Wall St. Rank hold ATEX as of Q1 2021.

  • IndexIQ Advisors reported no remaining Anterix position as of Q1 2021 after selling out during the quarter.
  • IndexIQ Advisors sold 4,586 Anterix shares in Q1 2021, an estimated $172K.
  • IndexIQ Advisors first reported a position in Anterix in Q1 2020 and held it in 4 quarters.
  • IndexIQ Advisors's Anterix position peaked at $196K in Q1 2020.
  • 97 funds tracked by Wall St. Rank held Anterix as of Q1 2021.

Based on IndexIQ Advisors's 13F filing for Q1 2021, filed 7 May 2021.